GPR55: ” a likely cannabinoid receptor.”


EnglishFrenchGermanHungarianItalianPolishPortugueseRussianSpanish

function googleTranslateElementInit2() {new google.translate.TranslateElement({pageLanguage: ‘en’,autoDisplay: false}, ‘google_translate_element2’);}

/* <![CDATA[ */
function GTranslateFireEvent(element,event){try{if(document.createEventObject){var evt=document.createEventObject();element.fireEvent('on'+event,evt)}else{var evt=document.createEvent('HTMLEvents');evt.initEvent(event,true,true);element.dispatchEvent(evt)}}catch(e){}}function doGTranslate(lang_pair){if(lang_pair.value)lang_pair=lang_pair.value;if(lang_pair=='')return;var lang=lang_pair.split('|')[1];var teCombo;var sel=document.getElementsByTagName('select');for(var i=0;i */

GPR55 could play deleterious role in ox-LDL-induced foam cells and could be a novel pharmacological target to manage atherosclerosis and other related cardiovascular diseases. Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation. This gene belongs to the G-protein-coupled receptor superfamily. The encoded integral membrane protein is a likely cannabinoid receptor. It may be involved in several physiological and pathological processes by activating a variety of signal transduction pathways. cialis italia generico

http://www.ncbi.nlm.nih.gov/gene/9290 getting viagra korea

 

Anonymous

 

Leave a Reply